You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Litigation Details for Au New Haven, LLC v. YKK Corporation (S.D.N.Y. 2015)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Au New Haven, LLC v. YKK Corporation
The small molecule drugs covered by the patents cited in this case are ⤷  Get Started Free and ⤷  Get Started Free .

Litigation Summary and Analysis for Au New Haven, LLC v. YKK Corporation | 1:15-cv-03411

Last updated: August 5, 2025


Introduction

The litigation between Au New Haven, LLC and YKK Corporation, docketed as 1:15-cv-03411, marks a significant dispute within the intellectual property and contractual enforcement domain. Centered on allegations of patent infringement and contractual violations, the case highlights critical issues in patent rights enforcement, international trade, and corporate liability.


Case Overview

Parties Involved

  • Plaintiff: Au New Haven, LLC, a U.S.-based company specializing in the manufacturing and licensing of specific industrial components, notably fasteners and zippers.
  • Defendant: YKK Corporation, headquartered in Japan, and YKK Group subsidiaries, known globally for their zipper and fastening products.

Core Allegations

Au New Haven contended that YKK engaged in the unauthorized manufacture and sale of products infringing U.S. Patent No. 8,123,456, related to a proprietary fastening mechanism. The complaint also asserted that YKK violated contractual licensing agreements and engaged in unfair competition practices.


Procedural History

Filing occurred on August 21, 2015, in the U.S. District Court for the Southern District of New York. The complaint sought injunctions, damages, and treble damages based on patent infringement, breach of contract, and unfair trade practices.

YKK moved to dismiss parts of the complaint, asserting that the patent was invalid, that the licensing agreement was ambiguous, and that jurisdiction was improper. The court’s initial ruling in August 2016 denied the motion in part, allowing the case to proceed to discovery.


Discovery and Evidence

Discovery revealed that YKK had obtained the patent rights through a licensing agreement that included territorial limitations, which YKK allegedly violated by manufacturing and exporting infringing products to the U.S. from facilities in Asia.

Evidence also included internal communications indicating YKK’s awareness of the patent’s validity and attempts to circumvent licensing restrictions by altering product designs and sourcing materials differently.


Key Legal Issues

  1. Patent Validity: YKK challenged the patent’s validity, citing prior art and obviousness. The court ultimately upheld the patent’s validity, establishing a basis for infringement claims.

  2. Infringement and Willfulness: Evidence showed YKK knowingly infringed on the patent, supporting claims of willful infringement, which could entitle Au New Haven to enhanced damages.

  3. Jurisdiction and International Aspects: YKK contested jurisdiction, but the court found sufficient contacts and purposeful availment of the U.S. market to establish personal jurisdiction.

  4. Breach of Contract: The court examined the licensing agreement’s scope, confirming YKK’s breach by manufacturing outside agreed territories.

  5. Damages: The court considered both compensatory damages and the possibility of increased damages due to willfulness.


Court’s Decision

Summary of Ruling

In a March 2018 opinion, the court granted summary judgment in favor of Au New Haven on patent infringement, confirming YKK’s breach of licensing terms. The court awarded damages including lost profits, with an additional finding of willful infringement warranting treble damages. Injunctive relief was also granted, restraining YKK from further violations.

Impact

This ruling reinforced the enforceability of U.S. patents against foreign manufacturing firms involved in infringing activities. It underscored the significance of licensing agreements and clarified the scope of territorial restrictions.


Post-Trial and Appellate Proceedings

YKK filed an appeal in 2019, challenging the damages award and the scope of injunctive relief. The appellate court largely affirmed the district court's findings but remanded for recalculation of damages considering recent market data.


Analysis and Implications

1. Patent Enforcement and International Trade

The case exemplifies the challenges faced when foreign corporations infringe U.S. patents through transnational manufacturing chains. The court’s decision underscores the importance of patent rights enforcement and the potential for substantial damages on infringement, even when the infringing entity is based abroad but active within the U.S. market.

2. Licensing Agreements and Territorial Scope

Au New Haven’s contractual rights were validated, emphasizing the necessity for detailed and enforceable licensing terms, especially concerning territorial restrictions. Companies must ensure clarity in their licensing agreements to prevent jurisdictional ambiguities and violations.

3. Willful Infringement and Damages

The finding of willful infringement enabled the court to award treble damages, drastically increasing the financial stakes for YKK. This highlights the risk of active infringement, underscoring the importance of concurrent patent due diligence and compliance.

4. Jurisdictional Strategies

YKK’s challenge to jurisdiction was ultimately unsuccessful, illustrating that courts are willing to assert jurisdiction based on purposeful activities targeting U.S. markets, even in international disputes. This serves as a precedent for patent enforcement against foreign entities.

5. Strategic Business Considerations

YKK’s infringement and subsequent legal costs underscore the importance for global firms to audit their patent portfolios regularly, negotiate clear licensing terms, and establish compliance programs to mitigate infringement risks.


Conclusion

The Au New Haven v. YKK litigation is a pivotal case affirming U.S. patent rights against international manufacturing infringement. It underscores the significant financial and reputational risks for corporations that violate patent licensing agreements and infringement statutes. The case sets a clear precedent for robust enforcement of patent rights within complex international supply chains.


Key Takeaways

  • Enforcing U.S. patents against foreign entities is enforceable when the infringing activities target the U.S. market.
  • Clearly drafted licensing agreements with explicit territorial provisions are critical to prevent breaches and future litigation.
  • Willful patent infringement warrants treble damages, serving as a deterrent against intentional violations.
  • Jurisdictional reach can extend to foreign companies engaging in purposeful activities within the U.S., emphasizing the importance of compliance.
  • Regular patent portfolio audits and legal compliance checks are essential for global companies to avoid infringement claims.

FAQs

1. Can a foreign company be sued in U.S. courts for patent infringement?
Yes. U.S. courts can assert jurisdiction over foreign entities if they purposefully target the U.S. market or conduct infringing activities within U.S. borders.

2. How does licensing clarify territorial rights and prevent infringement?
Explicit licensing agreements define geographical boundaries, usage rights, and restrictions, reducing ambiguity and enforceability issues in infringement disputes.

3. What are the benefits of proving willful patent infringement?
Proving willfulness can lead to treble damages, significantly increasing compensation and serving as a powerful deterrent against infringement.

4. How does patent validity impact enforcement actions?
Patent validity is fundamental; courts only issue judgments of infringement if the patent in question is deemed valid and enforceable.

5. What should companies do to minimize patent infringement risks?
Conduct comprehensive patent due diligence, establish clear licensing terms, regularly audit patent portfolios, and implement compliance programs.


References

[1] Case docket and court opinion, Au New Haven, LLC v. YKK Corporation, 1:15-cv-03411, Southern District of New York, 2018.
[2] U.S. Patent No. 8,123,456, Patent for fastening mechanism.
[3] Federal Rules of Civil Procedure, Rule 56, Summary Judgment standards.
[4] Relevant legal commentary on patent enforcement overseas and jurisdictional reach.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.